Metagenics supports women's whole body health with scientifically designed supplements for lasting wellbeing.*
Hormone-free multi-symptom menopause relief designed to bring women's bodies back into balance.*
- Clinically proven to reduce 12 of the most common menopausal symptoms including hot flashes by up to 83%*ǂ2
- Contains ERr 731, a plant-based ingredient with a two-year safety study*6
- Safe for long-term use with no change in safety parameters over two years*3
- No changes in gynecological findings (e.g., endometrial hyperplasia or abnormalities in breast tissue) and safety parameters were observed in a two-year observational study*†
Once-daily oral probiotic clinically proven to support lasting vaginal and urinary tract health.*
- The most clinically tested and effective combination of Lactobacillus rhamnosus GR-1® and Lactobacillus reuteri RC-14® to support the vaginal and urogenital health*
- Both strains within UltraFlora Women’s can survive passage through the gastrointestinal tract after oral intake and colonize the vagina to support an optimal environment for beneficial microbiota1
- More than 20 years of clinical evaluation support the safety and efficacy of each strain*
- Helps support a healthy vaginal microflora and balance good bacteria*
- Clinically-proven safe for long-term use; can be taken consistently for continuous urogenital support*
- 92% of women taking UltraFlora Women’s experienced improved urinary tract health*†
Get to the root of whole-body health with Metagenics.
Metagenics is committed to creating scientifically formulated supplements and medical foods using pure and potent ingredients sourced from nature. Our products are designed to nourish your body's systems and help you achieve optimal wellness. Nourish your systems, not just your symptoms.
Metagenics: The science that creates balance.™
Practitioner Recommended*ǂǂ
†Survey conducted online by Metagenics March 2023 with 664 women currently or previously taking UltraFlora Women’s.
†† Survey conducted online by Metagenics March 2023 with 424 women currently or previously taking Estrovera.
††† Survey conducted online by Metagenics September 21 to October 5, 2020 with 75 women currently taking Estrovera
ǂ Compared with perimenopausal women receiving placebo, those receiving ERr 731 (the extract found in Estrovera) experienced decreases in symptoms as indicated by the mean reduction in individual Menopause Rating Scale scores
ǂǂ These reviews have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
1. Reid G et al. FEMS Immunol Med Microbiol. 2006;30(1):49-52.
2. Kaszkin-Bettag M et al. Altern Ther Health Med. 2009;15(1):24-34
3. Chang J et al. Integr Med (Encinitas): 2016;15(3):34-39.5.
4. Hasper I et al. Menopause. 2009;16:117-131.
5. Winther K et al. Climacteric. 2005;8(2):162-170.